EMERGING MARKETS NEWS

• Humanwell’s remimazolam nails another indication nod in China

  2022-09-30

• Biosyngen’s FIC BRG01 under IND review in China

  2022-09-30

• Zai Lab‘s product sales up 64% YOY in H1 2022

  2022-09-30

• Alphamab’s Phase II study for KN019 reaches primary endpoint

  2022-09-30

• Brazil’s Cellera rumored to seek license for Janssen’s opioid Tylex

  2022-10-07

• Colombia’s INVIMA suffers second cyberattack this year

  2022-10-07

CLIENTS WE SERVE